Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Drug Candidates
100,0
%
| 92 | 100,0 % | 90 | 100,0 % | -2,10% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Rest of World
87,3
%
| 82 | 89,3 % | 79 | 87,3 % | -4,35% |
United States
12,7
%
| 10 | 10,7 % | 11 | 12,7 % | +16,66% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 01-01-07 |
Robert Chess
CHM | Chairman | 66 | 01-12-91 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 17-04-23 |
Chief Tech/Sci/R&D Officer | 49 | 01-07-15 | |
Mary Tagliaferri
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-01-15 |
Vivian Wu
IRC | Investor Relations Contact | - | 01-11-18 |
Robert Bacci
HRO | Human Resources Officer | - | 01-01-01 |
Mark Wilson
LAW | General Counsel | 52 | 01-05-02 |
Jennifer Ruddock
PRN | Corporate Officer/Principal | - | 01-01-04 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
R. Scott Greer
BRD | Director/Board Member | 65 | 01-01-10 |
Roy A. Whitfield
BRD | Director/Board Member | 70 | 01-08-00 |
Robert Chess
CHM | Chairman | 66 | 01-12-91 |
Howard Robin
CEO | Chief Executive Officer | 71 | 01-01-07 |
Jeff Ajer
BRD | Director/Board Member | 61 | 21-09-17 |
Myriam Curet
BRD | Director/Board Member | 67 | 16-12-19 |
Diana Brainard
BRD | Director/Board Member | 53 | 11-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 183 617 817 | 182 108 535 ( 99,18 %) | 0 | 99,18 % |
Bedrijfsgegevens
Nektar Therapeutics
455 Mission Bay Boulevard South
94158, San Francisco
+415 482 5300
http://www.nektar.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Nektar Therapeutics (India) Pvt Ltd.
Nektar Therapeutics (India) Pvt Ltd. BiotechnologyHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics (India) Pvt Ltd. develops biopharmaceutical products. The private company is based in Hyderabad, India. |
Biotechnology
|
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |